HeartSciences (HSCS) Depreciation & Amortization (CF) (2021 - 2026)
HeartSciences (HSCS) reported Depreciation & Amortization (CF) of $6916.0 for Q1 2026, up 15.13% on a YoY basis from $6007.0 in Q1 2025, and down 1.28% quarter-over-quarter from $7006.0 in Q4 2025.
HeartSciences (HSCS) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
HeartSciences has reported Depreciation & Amortization (CF) for 6 years, with the latest figure at $6916.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 15.13% year-over-year to $6916.0; the trailing twelve-month figure through Jan 2026 stood at $28546.0 (down 27.34% YoY), and the FY2025 full-year result was $37599.0, up 34.8% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $6916.0, down from $7006.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $12215.0 in Q4 2024, with the low at $3717.0 in Q1 2024.
- Historically, Depreciation & Amortization (CF) has averaged $7437.1 across 5 years, with a median of $6916.0 in 2026.
- The largest YoY upside for Depreciation & Amortization (CF) was 61.68% in 2024 against a maximum downside of 45.86% in 2024.
- HeartSciences' Depreciation & Amortization (CF) stood at $6813.0 in 2022, then grew by 12.08% to $7636.0 in 2023, then jumped by 59.97% to $12215.0 in 2024, then tumbled by 42.64% to $7006.0 in 2025, then retreated by 1.28% to $6916.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $6916.0 (Q1 2026), $7006.0 (Q4 2025), and $7111.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | HeartSciences | 3.89 Mn | 492,884.20 | - | 6,916.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 6,916.00 |
| Jan 31, 2026 | 6,916.00 |
| Oct 31, 2025 | 7,006.00 |
| Oct 31, 2025 | 7,006.00 |
| Jul 31, 2025 | 7,111.00 |
| Jul 31, 2025 | 7,111.00 |
| Apr 30, 2025 | 7,513.00 |
| Apr 30, 2025 | 7,513.00 |
| Jan 31, 2025 | 6,007.00 |
| Jan 31, 2025 | 6,007.00 |
| Oct 31, 2024 | 12,215.00 |
| Oct 31, 2024 | 12,215.00 |
| Jul 31, 2024 | 11,864.00 |
| Jul 31, 2024 | 11,864.00 |
| Apr 30, 2024 | 9,201.00 |
| Apr 30, 2024 | 9,201.00 |
| Jan 31, 2024 | 3,717.00 |
| Jan 31, 2024 | 3,717.00 |
| Oct 31, 2023 | 7,636.00 |
| Oct 31, 2023 | 7,636.00 |